Shigemi A - Search Results

1

Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.

Matsubara K, Matsumoto K, Yokoyama Y, Watanabe E, Enoki Y, Shigemi A, Ikawa K, Terazono H, Morikawa N, Ohshige T, Takeda Y. Matsubara K, et al. Among authors: shigemi a. Biol Pharm Bull. 2021;44(5):732-736. doi: 10.1248/bpb.b20-00781. Biol Pharm Bull. 2021. PMID: 33952829 Free article.

2

Enhanced measures, including PCR-based screening and syndromic surveillance for nosocomial outbreaks of the COVID-19 Omicron variant, using descriptive epidemiology and whole-genome sequencing in a Japanese tertiary care hospital.

Kawamura H, Arimura S, Saida R, Murata N, Shigemi A, Kodama Y, Nakamura M, Obama Y, Fukuyama R, Hamada Y, Shinkawa N, Sunagawa T, Kamiya H, Nishi J. Kawamura H, et al. Among authors: shigemi a. J Infect Chemother. 2024 Feb;30(2):104-110. doi: 10.1016/j.jiac.2023.09.015. Epub 2023 Sep 17. J Infect Chemother. 2024. PMID: 37717606 Free article.

3

Renal function as a predictor of linezolid-induced thrombocytopenia.

Matsumoto K, Takeda Y, Takeshita A, Fukunaga N, Shigemi A, Yaji K, Shimodozono Y, Yamada K, Ikawa K, Morikawa N. Matsumoto K, et al. Among authors: shigemi a. Int J Antimicrob Agents. 2009 Jan;33(1):98-9. doi: 10.1016/j.ijantimicag.2008.07.002. Epub 2008 Sep 14. Int J Antimicrob Agents. 2009. PMID: 18790615 No abstract available.

4

Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.

Shigemi A, Matsumoto K, Yaji K, Shimodozono Y, Takeda Y, Miyanohara H, Kawamura H, Orita M, Tokuda K, Nishi J, Yamada K. Shigemi A, et al. Int J Antimicrob Agents. 2009 Dec;34(6):589-91. doi: 10.1016/j.ijantimicag.2009.07.017. Epub 2009 Sep 11. Int J Antimicrob Agents. 2009. PMID: 19748231

5

Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections.

Matsumoto K, Kanazawa N, Ikawa K, Fukamizu T, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Matsumoto K, et al. Among authors: shigemi a. J Infect Chemother. 2010 Jun;16(3):193-9. doi: 10.1007/s10156-010-0038-8. Epub 2010 Mar 2. J Infect Chemother. 2010. PMID: 20195882

6

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.

Matsumoto K, Takeshita A, Ikawa K, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Matsumoto K, et al. Among authors: shigemi a. Int J Antimicrob Agents. 2010 Aug;36(2):179-81. doi: 10.1016/j.ijantimicag.2010.02.019. Epub 2010 Apr 13. Int J Antimicrob Agents. 2010. PMID: 20392606

7

An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.

Kanazawa N, Matsumoto K, Ikawa K, Fukamizu T, Shigemi A, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Kanazawa N, et al. Among authors: shigemi a. J Infect Chemother. 2011 Apr;17(2):297-300. doi: 10.1007/s10156-010-0105-1. Epub 2010 Aug 17. J Infect Chemother. 2011. PMID: 20714913

8

Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.

Shigemi A, Matsumoto K, Ikawa K, Yaji K, Shimodozono Y, Morikawa N, Takeda Y, Yamada K. Shigemi A, et al. Int J Antimicrob Agents. 2011 Nov;38(5):417-20. doi: 10.1016/j.ijantimicag.2011.07.004. Epub 2011 Aug 31. Int J Antimicrob Agents. 2011. PMID: 21885259

9

Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves.

Matsumoto K, Shigemi A, Yaji K, Shimodozono Y, Takeda Y, Ikawa K, Morikawa N, Miyanohara H, Kawamura H, Orita M, Tokuda K, Nishi J, Yamada K. Matsumoto K, et al. Among authors: shigemi a. J Infect Chemother. 2012 Apr;18(2):269-71. doi: 10.1007/s10156-011-0291-5. Epub 2011 Sep 6. J Infect Chemother. 2012. PMID: 21894454

10

Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.

Yokoyama Y, Matsumoto K, Ikawa K, Watanabe E, Shigemi A, Umezaki Y, Nakamura K, Ueno K, Morikawa N, Takeda Y. Yokoyama Y, et al. Among authors: shigemi a. Int J Antimicrob Agents. 2014 Jun;43(6):547-52. doi: 10.1016/j.ijantimicag.2014.02.012. Epub 2014 Mar 30. Int J Antimicrob Agents. 2014. PMID: 24796218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page